Mali Gana Weisz
Overview
Explore the profile of Mali Gana Weisz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
169
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sade O, Fischel D, Barak-Broner N, Halevi S, Gottfried I, Bar-On D, et al.
Front Mol Neurosci
. 2024 Sep;
17:1431549.
PMID: 39296283
Alpha-synuclein (aSyn) aggregates in the central nervous system are the main pathological hallmark of Parkinson's disease (PD). ASyn aggregates have also been detected in many peripheral tissues, including the skin,...
2.
Shiner T, Kave G, Mirelman A, Regev K, Piura Y, Goldstein O, et al.
Mov Disord
. 2024 Aug;
39(12):2280-2285.
PMID: 39212252
Background: Glucocerebrosidase 1 (GBA1) mutations are associated with reduced survival in Parkinson's disease but their effect on survival in dementia with Lewy bodies (DLB) is unclear. Objective: To assess the...
3.
Omer N, Droby A, Silbak R, Trablus N, Bar David A, Shiner T, et al.
J Neurol Neurosurg Psychiatry
. 2024 Jul;
PMID: 39084863
Background: MRI is an important tool for disease diagnosis of Creutzfeldt-Jakob disease (CJD), yet its role in identifying preclinical stages of disease remains unclear. Here, we explored subtle white matter...
4.
Schejter-Margalit T, Binyamin N, Thaler A, Maidan I, Cedarbaum J, Orr-Urtreger A, et al.
Eur J Neurol
. 2024 May;
31(8):e16327.
PMID: 38743695
Background And Purpose: Subtle executive dysfunction is common in people newly diagnosed with Parkinson disease (PD), even when general cognitive abilities are intact. This study examined the Short Weekly Calendar...
5.
Shiner T, Mirelman A, Rosenblum Y, Kave G, Gana Weisz M, Bar-Shira A, et al.
J Alzheimers Dis
. 2021 Mar;
80(3):1221-1229.
PMID: 33646158
Background: Glucocerebrosidase (GBA) gene mutations and APOE polymorphisms are common in dementia with Lewy bodies (DLB), however their clinical impact is only partially elucidated. Objective: To explore the clinical impact...
6.
Bregman N, Kave G, Mirelman A, Thaler A, Gana Weisz M, Bar-Shira A, et al.
Alzheimer Dis Assoc Disord
. 2019 Jan;
33(3):279-281.
PMID: 30640255
Cognitive deficits beyond memory impairment, such as those affecting language production or executive functioning, can be useful in clinically distinguishing between dementia syndromes. We tested the hypothesis that Ashkenazi Jewish...
7.
Thaler A, Gurevich T, Bar Shira A, Gana Weisz M, Ash E, Shiner T, et al.
Parkinsonism Relat Disord
. 2016 Dec;
36:47-51.
PMID: 28012950
Objective: Mutations in the GBA gene are associated with Parkinson's disease (PD). A definite description of the clinical characteristics of PD patients who are compound heterozygotes or homozygotes for mutations...
8.
Shiner T, Mirelman A, Gana Weisz M, Bar-Shira A, Ash E, Cialic R, et al.
JAMA Neurol
. 2016 Oct;
73(12):1448-1453.
PMID: 27723861
Importance: Mutations in the glucocerebrosidase (GBA) gene are a risk factor for the development of dementia with Lewy bodies (DLB). These mutations are common among Ashkenazi Jews (AJ) and appear...
9.
Alcalay R, Mirelman A, Saunders-Pullman R, Tang M, Mejia Santana H, Raymond D, et al.
Mov Disord
. 2013 Nov;
28(14):1966-71.
PMID: 24243757
The phenotype of Parkinson's disease (PD) in patients with and without leucine-rich repeat kinase 2 (LRRK2) G2019S mutations reportedly is similar; however, large, uniformly evaluated series are lacking. The objective...